| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, September 2007, p. 3391-3393, Vol. 51, No. 9
0066-4804/07/$08.00+0 doi:10.1128/AAC.00473-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana
Received 5 April 2007/ Returned for modification 15 June 2007/ Accepted 2 July 2007
We examined the susceptibility of Haemophilus ducreyi to antimicrobial peptides likely to be encountered in vivo during human infection. H. ducreyi was significantly more resistant than Escherichia coli to the bactericidal effects of all peptides tested. Class I and II H. ducreyi strains exhibited similar levels of resistance to antimicrobial peptides.
Published ahead of print on 9 July 2007.
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |